Status:
COMPLETED
Feasibility and Safety of Physical Exercise in Men With Prostate Cancer
Lead Sponsor:
Azienda USL Reggio Emilia - IRCCS
Collaborating Sponsors:
Fondazione Manodori di Reggio Emilia
University of Modena and Reggio Emilia
Conditions:
Prostate Cancer
Androgen Deprivation Therapy
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Prostate cancer (PCa) is among the most widespread in the male population and represents 19% of all cancers diagnosed from the age of fifty, in Italy. Androgen deprivation therapy (ADT) and Radiothera...
Detailed Description
The non-randomized feasibility and pilot study aims to evaluate the feasibility and safety of a structured, multicomponent, supervised and unsupervised exercise program. Secondary outcome will be eva...
Eligibility Criteria
Inclusion
- Histologically documented diagnosis of PCa;
- Undergo ADT and RT during the study period;
- At least 18 years old;
- Willing and able to give written informed consent;
- Able to read and understand Italian Language;
Exclusion
- Musculoskeletal, cardiovascular, neurological or psychiatric disorders that contraindicate participation in an exercise program.
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04500080
Start Date
April 14 2020
End Date
September 30 2022
Last Update
October 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda USL-IRCCS di Reggio Emilia
Reggio Emilia, Emilia-Romagna, Italy, 42123